Business / Health

Add as a preferred source on Google

Nigeria's Listed Drugmakers Lift Capital Spending 81% to N29.26 Billion

BusinessDay said the investment was intended to expand manufacturing capacity.

Updated 1 min read
Workers monitor a tablet packaging line inside a pharmaceutical plant in Lagos, Nigeria. (AI-generated image / EconoTimes)
Workers monitor a tablet packaging line inside a pharmaceutical plant in Lagos, Nigeria. (AI-generated image / EconoTimes)

Capital spending by Nigeria’s five listed pharmaceutical manufacturers rose 81% to N29.26 billion during 2026's first three quarters, BusinessDay reported, as companies sought to expand production.

BusinessDay said the investment was intended to expand manufacturing capacity. Earlier EconoTimes coverage has examined imported active-ingredient risks facing Nigerian drugmakers.

Related articles

View all